AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
3.480
-0.150 (-4.13%)
At close: Jul 19, 2024, 4:00 PM
3.500
+0.020 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $345.21 million as of July 22, 2024. Its market cap has increased by 43.84% in one year.
Market Cap
345.21M
Enterprise Value
230.88M
1-Year Change
43.84%
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $345.21M, a decrease of -60.21%. That is a compound annual growth rate of -11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 345.20M | -18.51% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Talkspace | 358.04M |
| Vanda Pharmaceuticals | 355.59M |
| Cartesian Therapeutics | 354.90M |
| Q32 Bio | 351.81M |
| Xeris Biopharma Holdings | 350.63M |
| Cabaletta Bio | 342.28M |
| ModivCare | 335.24M |
| Nevro | 334.23M |